BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22543347)

  • 1. Update on the diagnosis and management of hypophysitis.
    Carmichael JD
    Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):314-21. PubMed ID: 22543347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current update on hypophysitis].
    Allix I; Rohmer V
    Rev Med Interne; 2014 Dec; 35(12):815-22. PubMed ID: 25109447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypophysitis: increasingly complex clinicopathological spectrum!].
    Allix I; Rohmer V
    Ann Endocrinol (Paris); 2012 Oct; 73 Suppl 1():S17-25. PubMed ID: 23089377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease.
    Torino F; Barnabei A; De Vecchis L; Salvatori R; Corsello SM
    Oncologist; 2012; 17(4):525-35. PubMed ID: 22477725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune hypophysitis: autoantigens and association with CTLA-4 blockade.
    Caturegli P
    Ann Endocrinol (Paris); 2012 Apr; 73(2):78. PubMed ID: 22537512
    [No Abstract]   [Full Text] [Related]  

  • 6. Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review.
    Juszczak A; Gupta A; Karavitaki N; Middleton MR; Grossman AB
    Eur J Endocrinol; 2012 Jul; 167(1):1-5. PubMed ID: 22495490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipituitary antibodies in patients with suspected autoimmune hypophysitis].
    Moya Chimenti E; Alvarez Doforno R; Villaroel Bajo A; Frutos R; Pallardo Sánchez LF; Alvarez Escolá C
    Endocrinol Nutr; 2010 Apr; 57(4):160-4. PubMed ID: 20385514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoimmune hypophysitis].
    Krarup T; Hagen C
    Ugeskr Laeger; 2010 Mar; 172(11):875-80. PubMed ID: 20412729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA Markers DQ8 and DR53 Are Associated With Lymphocytic Hypophysitis and May Aid in Differential Diagnosis.
    Heaney AP; Sumerel B; Rajalingam R; Bergsneider M; Yong WH; Liau LM
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4092-7. PubMed ID: 26317559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient.
    Kaehler KC; Egberts F; Lorigan P; Hauschild A
    Melanoma Res; 2009 Oct; 19(5):333-4. PubMed ID: 19512947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophysitis in 2014.
    Allix I; Rohmer V
    Ann Endocrinol (Paris); 2015 Oct; 76(5):585-94. PubMed ID: 26514950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes.
    Dillard T; Yedinak CG; Alumkal J; Fleseriu M
    Pituitary; 2010; 13(1):29-38. PubMed ID: 19639414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoimmune hypophysitis or lymphocytic hypophysitis].
    Paiva I; Gomes L; Ribeiro C; Carvalheiro M; Ruas MM
    Acta Med Port; 2003; 16(6):459-63. PubMed ID: 15631859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody.
    Iwama S; De Remigis A; Callahan MK; Slovin SF; Wolchok JD; Caturegli P
    Sci Transl Med; 2014 Apr; 6(230):230ra45. PubMed ID: 24695685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune phenomena involving the pituitary gland in children: New developing data about diagnosis and treatment.
    Romano A; Rigante D; Cipolla C
    Autoimmun Rev; 2019 Oct; 18(10):102363. PubMed ID: 31401342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma.
    Albarel F; Gaudy C; Castinetti F; Carré T; Morange I; Conte-Devolx B; Grob JJ; Brue T
    Eur J Endocrinol; 2015 Feb; 172(2):195-204. PubMed ID: 25416723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease.
    Wong S; Lam WY; Wong WK; Lee KC
    Hum Pathol; 2007 Nov; 38(11):1720-3. PubMed ID: 17954209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and clinical aspects of lymphocytic hypophysitis.
    De Bellis A; Ruocco G; Battaglia M; Conte M; Coronella C; Tirelli G; Bellastella A; Pane E; Sinisi AA; Bizzarro A; Bellastella G
    Clin Sci (Lond); 2008 Mar; 114(6):413-21. PubMed ID: 18260829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel autoantigens in autoimmune hypophysitis.
    Lupi I; Broman KW; Tzou SC; Gutenberg A; Martino E; Caturegli P
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):269-78. PubMed ID: 18194487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.
    Caturegli P; Di Dalmazi G; Lombardi M; Grosso F; Larman HB; Larman T; Taverna G; Cosottini M; Lupi I
    Am J Pathol; 2016 Dec; 186(12):3225-3235. PubMed ID: 27750046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.